Last quarter (Q4 2023), Summit Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Summit Therapeutics's net income was $-1.08B. See Summit Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 584.00K	-	$ 705.00K	$ 1.81M	$ 860.00K	$ 743.00K
Cost of Revenue	-	-	-	-	-	$ 1.00K
Gross Profit	$ 584.00K	-	$ 15.12M	$ 22.78M	-	$ 582.00K
Operating Expense	$ 610.68M	$ 610.65M	$ -87.21M	$ -108.96M	$ 53.16M	$ 28.22M
Operating Income	$ -609.65M	$ -609.65M	$ -63.62M	$ -86.19M	$ -52.30M	$ -27.47M
Net Non Operating Interest Income Expense	$ -15.12M	$ -16.46M	$ -6.69M	$ -2.42M	$ -251.00K	$ -286.00K
Other Income Expense	$ -361.00K	$ 5.28M	$ 8.47M	$ -6.44M	$ -325.00K	$ -1.33M
Pretax Income	$ -1.66B	$ -614.93M	$ -78.78M	$ -88.60M	$ -52.91M	$ -29.09M
Tax Provision	-	-	-	-	$ -213.00K	$ 36.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -1.66B	$ -614.93M	$ -78.78M	$ -88.60M	$ -52.70M	$ -29.13M
Basic EPS	$ -1.53	$ -0.99	$ -0.41	$ -0.96	$ -0.76	$ -0.89
Diluted EPS	$ -1.53	$ -0.99	$ -0.41	$ -0.96	$ -0.76	$ -0.89
Basic Average Shares	$ 2.48B	$ 619.65M	$ 193.34M	$ 92.24M	$ 69.52M	$ 164.15M
Diluted Average Shares	$ 2.48B	$ 619.65M	$ 193.34M	$ 92.24M	$ 69.52M	$ 164.15M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 538.66M	$ 610.65M	$ -87.21M	$ -108.96M	$ 53.16M	$ 28.22M
Net Income From Continuing And Discontinued Operation	$ -614.93M	$ -614.93M	$ -78.78M	$ -88.60M	$ -52.70M	$ -29.13M
Normalized Income	$ -16.80M	$ -486.32M	-	-	$ -51.90M	$ -28.15M
Interest Expense	-	-	-	-	$ 255.00K	$ 291.00K
EBIT	$ -567.90M	$ -609.12M	$ -83.18M	$ -86.19M	$ -52.66M	$ -28.80M
EBITDA	$ -568.17M	$ -608.99M	$ -80.67M	$ -83.73M	$ -50.65M	$ -27.16M

Currency in USD

Summit Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing